# Venous and Cerebral Glucose Microdialysis in Neurocritical Care: Validation & Correlation

> **NCT03246607** · — · UNKNOWN · sponsor: **Dr Andrew Stevens** · enrollment: 20 (estimated)

## Conditions studied

- Traumatic Brain Injury
- Acquired Brain Injury
- Intracerebral Hemorrhage
- Subarachnoid Hemorrhage
- Ischemic Stroke

## Interventions

- **DEVICE:** MicroEye & ContinuMon

## Key facts

- **NCT ID:** NCT03246607
- **Lead sponsor:** Dr Andrew Stevens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-26
- **Primary completion:** 2020-08-02
- **Final completion:** 2020-10-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03246607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03246607, "Venous and Cerebral Glucose Microdialysis in Neurocritical Care: Validation & Correlation". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03246607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
